Author: openjargon

  • VGS vs VHY: Which Vanguard ETF comes out on top?

    Person working on a computer with a hologram of the word ETF along with finance-related images.

    Investors looking for a simple way to diversify their portfolios have plenty of Vanguard ETFs to choose from. But the popular Vanguard MSCI Index International Shares ETF (ASX: VGS) and Vanguard Australian Shares High Yield ETF (ASX: VHY) take very different approaches.

    VGS offers global exposure and a tilt towards growth, while VHY focuses on high-yielding Australian shares.

    So, which Vanguard ETF comes out on top?

    VGS: Global growth in one ETF

    This popular Vanguard ETF invests in around 1,300 companies across developed markets worldwide.

    The US accounts for the bulk of the portfolio, with exposure to countries including Japan, the UK, Canada, France, Switzerland and Germany.

    Its largest holdings include NVIDIA, Apple, and Microsoft. That gives investors exposure to some of the world’s biggest technology companies, alongside businesses across healthcare, consumer and industrial sectors. 

    VGS charges a management fee of 0.18% per year. Over the past 12 months, it has delivered a return of around 7.4%. Over the past 10 years, the Vanguard ETF has returned approximately 184%.

    VGS also recently paid a distribution of around 80 cents per unit.

    VHY: The dividend-focused alternative

    This popular Vanguard ETF takes a completely different approach.

    Rather than looking overseas, VHY targets Australian companies with higher forecast dividend yields. Its major holdings include BHP Group Ltd (ASX: BHP), Westpac Banking Corp (ASX: WBC), Rio Tinto Ltd (ASX: RIO) and Telstra Group Ltd (ASX: TLS), alongside other major Australian companies. 

    For income-focused investors, that’s the major attraction. The fund carries a forecast yield of around 4.2%, rising to approximately 5.5% once franking credits are included.

    And VHY hasn’t exactly been left behind on performance. It delivered a 7.4% return over the past year and a return of 46% over the past decade. 

    VHY charges a 0.25% management fee, slightly more than VGS. Its portfolio also has significant exposure to the Australian banking and resources sectors, meaning investors aren’t getting the same geographic or sector diversification offered by VGS.

    Which Vanguard ETF wins?

    There isn’t an obvious winner for every investor. VHY could be the better fit for investors who prioritise regular dividend income and want exposure to established Australian businesses. The potential benefit of franking credits is another attraction for eligible Australian investors.

    VGS, meanwhile, offers something VHY simply can’t: global diversification and access to sectors such as technology that have a much smaller presence on the Australian share market. 

    For an investor focused primarily on long-term capital growth and diversification, I’d give VGS the edge.

    But for investors seeking income today, VHY has a compelling proposition.

    Ultimately, the better Vanguard ETF depends on whether your priority is global growth or Australian dividend income.

    The post VGS vs VHY: Which Vanguard ETF comes out on top? appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Vanguard Msci Index International Shares ETF right now?

    Before you buy Vanguard Msci Index International Shares ETF shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Vanguard Msci Index International Shares ETF wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Marc Van Dinther has positions in BHP Group. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Apple, Microsoft, and Nvidia. The Motley Fool Australia has positions in and has recommended Telstra Group. The Motley Fool Australia has recommended Apple, BHP Group, Microsoft, Nvidia, Vanguard Australian Shares High Yield ETF, and Vanguard Msci Index International Shares ETF. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Westgold Resources launches $100m Meekatharra expansion plan to boost output

    Calculator and gold bars on Australian dollars, symbolising dividends.

    The Westgold Resources Ltd (ASX: WGX) share price is in focus today after the company unveiled a major expansion plan for its Meekatharra processing hub, aiming to significantly boost gold production and improve future cashflow.

    What did Westgold Resources report?

    • Scoping Study for Meekatharra Expansion Plan (MXP) to lift processing capacity from 1.8Mtpa to 2.9Mtpa in FY28
    • Expected to add approximately 47,000 ounces per year to gold production, increasing total gold output to 1.6 million ounces over 10 years (up 424,000 ounces)
    • Indicative capital cost of $100 million with a targeted payback period of 9 months
    • All-in Sustaining Cost (AISC) range forecast between $1,968 – $2,406 per ounce for life-of-mine
    • Group NPV uplift of about $1.1 billion at $5,500/oz gold price, up to $1.6 billion at spot ($6,000/oz)
    • Westgold holds $939 million in cash, bullion and liquid investments as at 30 June 2026

    What else do investors need to know?

    The Meekatharra Expansion Plan is designed as a low-capital, brownfields upgrade, leveraging existing infrastructure and equipment that’s already on hand. By installing a parallel crushing and single-stage SAG milling circuit, Westgold aims to process more ore and unlock additional emerging supply, including increased outputs from the Bluebird–South Junction mine and several open pits in its Murchison Open Pit program.

    Resource definition drilling and open pit optimisation work has already commenced to further support and de-risk the expansion. Third-party ore purchase agreements are also in place, providing additional flexibility, although these are not critical to the project’s economics.

    What did Westgold Resources management say?

    Westgold Managing Director and CEO Wayne Bramwell said:

    The MXP is a capital-efficient brownfields expansion option to address this emerging constraint. It utilises existing infrastructure and long-lead equipment already procured to increase processing capacity from 1.8Mtpa to 2.9Mtpa, without the capital intensity, execution risk or timeframe of building a new plant.

    What’s next for Westgold Resources?

    Westgold will now move forward with feasibility-level studies, detailed engineering and execution planning for the Meekatharra expansion, aiming for a final investment decision in late FY27. Brownfields resource definition work will continue in parallel to secure additional future ore sources.

    If delivered as planned, the MXP is expected to lift installed capacity in FY28, setting up improved production, lower processing costs and enhanced free cash generation for the group. Production timing and costs remain subject to feasibility outcomes and final approvals.

    Westgold Resources share price snapshot

    Over the past 12 months, Westgold Resources shares have risen 97%, significantly outperforming the S&P/ASX 200 Index (ASX: XJO).

    View Original Announcement

    The post Westgold Resources launches $100m Meekatharra expansion plan to boost output appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Westgold Resources right now?

    Before you buy Westgold Resources shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Westgold Resources wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

  • What is this broker’s updated view on PLS shares after big results?

    Woman looking at her computer and pondering something.

    It has been a rollercoaster ride for PLS Group Ltd (ASX: PLS) shareholders in 2026. 

    The lithium-tantalum producer saw its share price open the year around $4.30 per share. 

    After a strong run for lithium shares amidst renewed sector optimism, its share price hit over $6.70 per share. 

    Investors’ happiness was short lived however, as it quickly plummeted back down to $4.00 per share in a matter of weeks. 

    Since then, it has slowly climbed back into the positive, before PLS shares roared back to life yesterday following full year results. 

    This volatility can make it difficult for investors to pinpoint true value. 

    However the team at Bell Potter have provided updated guidance for what investors can expect over the next 12 months. 

    What did PLS report?

    As reported by The Motley Fool yesterday, the company reported FY26 revenue up 152% to $1.93 billion and a shift to a $526 million net profit.

    Other results included: 

    • Underlying EBITDA: $1,137 million (59% margin; up from $97 million in FY25)
    • Net profit after tax: $526 million (from a $196 million loss in FY25)
    • Production: 879.5k tonnes spodumene concentrate (up 17%)
    • Final dividend: 5 cents per share, fully franked ($161 million distribution)
    • Cash balance: $2,290 million (up 135%). 

    Investors were seemingly pleased with these results as PLS shares rose by almost 8% yesterday. 

    Its share price is now up more than 150% in the last 12 months. 

    What is Bell Potter’s view?

    The broker saw the FY26 result as broadly in line with expectations, with strong cash generation and a better-than-expected 5c fully franked dividend. 

    However, PLS is now entering a large investment cycle, with FY27 capex expected to rise significantly as it progresses projects.

    Bell Potter expects the P2000 project could receive investment approval in late 2026, but estimates its cost at around $2.2bn, well above the earlier $1.2bn estimate. 

    While PLS has a strong balance sheet with $1.1bn net cash, Bell Potter believes the increased spending and PLS’s conservative approach to its balance sheet could limit shareholder returns in the medium term, despite only modest changes to its earnings forecasts.

    Hold recommendation for PLS shares

    Based on this guidance, the broker has a hold recommendation on PLS shares. 

    The broker also has a price target of $5.20 on PLS shares, indicating a 5% downside from current levels. 

    With the material step up in expenditure and the company’s track record for balance sheet conservatism, we believe shareholder returns could be constrained across the medium term.

    The post What is this broker’s updated view on PLS shares after big results? appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Pls Group right now?

    Before you buy Pls Group shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Pls Group wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Aaron Bell has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Coles Group grows profit and dividend as Supermarkets shine in FY26

    Woman checking bottle expiry dates.

    The Coles Group Ltd (ASX: COL) share price will be closely watched today after full-year sales revenue rose 2.8% to $45.6 billion and earnings (EBIT, excluding significant items) jumped 9.9%, led by strong Supermarkets performance.

    What did Coles Group report?

    • Group sales revenue up 2.8% to $45,580 million
    • EBIT (excluding significant items) up 9.9% to $2,322 million
    • NPAT (excluding significant items) up 13.7% to $1,255 million
    • Fully franked total dividend up 13.0% to 78 cents per share
    • Supermarkets sales revenue up 3.7%, EBIT up 12.2%
    • eCommerce Supermarkets sales grew 26.4% to $5.6 billion

    What else do investors need to know?

    Coles delivered strong returns from its core Supermarkets business, with EBIT margin expanding by 43 basis points and customer satisfaction scores improving. Notably, Exclusive to Coles sales grew 6.1%, and the company gained market share during the year.

    Liquor sales revenue fell 3.3% as the sector faced subdued consumer sentiment and higher costs, prompting the launch of a multi-year repositioning program. The group maintained a robust balance sheet with net assets of $3.95 billion and continued to invest in store renewals, automation, and digital technology.

    Coles declared a fully franked final dividend of 37 cents per share, taking dividends for the year to 78 cents — a 13% increase.

    What did Coles Group management say?

    Commenting on the results, Coles CEO, Leah Weckert, said:

    FY26 was another year of consistently strong performance for Coles, with above-market sales and strong earnings growth accompanied by further improvements in customer NPS and team member engagement. This demonstrates the benefits of our investments in automation and eCommerce, disciplined execution and a focus on delivering clear value for customers. We are now investing in the next phase of growth, including through an accelerated store opening and renewal program, coupled with a clear strategy to improve the performance of our Liquor business which will ensure Coles can maintain its growth trajectory.

    What’s next for Coles Group?

    Coles enters FY27 with positive momentum, especially across Supermarkets and digital operations, with sales growth tracking similarly to the final quarter of FY26. The business is ramping up investment in new stores, renewals, and technology—including accelerated eCommerce and supply chain automation.

    For Liquor, a strategic repositioning is underway to improve integration with Supermarkets, optimise the store network, and simplify operations. The company will also invest in its new Victorian automated distribution centre and the Coles Capability Centre to drive operational efficiencies and support long-term growth.

    Coles Group share price snapshot

    Over the past 12 months, the Coles Group share price has outperformed the S&P/ASX 200 index (ASX: XJO) with a gain of around 9%. This reflects ongoing investor confidence in the business’s steady performance and dividend growth.

    View Original Announcement

    The post Coles Group grows profit and dividend as Supermarkets shine in FY26 appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Coles Group right now?

    Before you buy Coles Group shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Coles Group wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

  • South32 share price in focus as Sierra Gorda mine life jumps with 61% reserve boost

    Business people standing at a mine site smiling.

    The South32 Ltd (ASX: S32) share price is in focus today after the company reported a substantial 61% jump in Sierra Gorda’s ore reserve estimate, extending the mine’s reserve life to 2045.

    What did South32 report?

    • Ore reserve at Sierra Gorda increased by 61% to 1,100 million tonnes at 0.39% total copper, 0.016% molybdenum, and 0.06 g/t gold (as at 31 July 2026).
    • Mineral resource estimate rose 8% to 1,870 million tonnes at 0.37% total copper, 0.016% molybdenum, and 0.06 g/t gold.
    • Reserve life extended by about five years, now expected until 2045.
    • Expansion follows successful infill drilling—around 85,000 metres drilled between 2023 and 2025.
    • Fourth grinding line project approved, projected to boost copper production by around 30% from 2031.

    What else do investors need to know?

    The Sierra Gorda copper mine, in which South32 holds a 45% stake, is a large, open pit operation in northern Chile. This major jump in ore reserves and resources comes after significant drilling to better define the orebody, providing more certainty over future production.

    July’s approval for a fourth grinding line is expected to increase annual processing capacity from 135,000 to 165,000 tonnes per day by 2031. The mine is already well-equipped with modern processing infrastructure, renewable energy, and seawater supply, helping support these plans.

    Exploration is underway at the Catabela Northeast zone, where early drilling results suggest more copper resources could be uncovered—potentially providing further mine life extensions in the future.

    What did South32 management say?

    South32 Chief Executive Officer, Matt Daley said:

    This update highlights the scale, quality and long-life orebody at Sierra Gorda, which we expect will be a significant source of copper for decades to come. It follows the approval in July to proceed with execution of the fourth grinding line project at Sierra Gorda, which is expected to increase copper production by approximately 30 per cent from 2031.

    With the current orebody remaining open at depth, the mine offers potential for further growth beyond today’s increase to ore reserve and reserve life. We continue to work with our joint venture partner to drive further growth and value at Sierra Gorda. This includes the Catabela Northeast exploration project, where exploration holes have intersected significant copper mineralisation, highlighting the potential for future mine life extension.

    What’s next for South32?

    South32 is focused on ramping up development at Sierra Gorda, progressing the fourth grinding line project and ongoing infill and exploration drilling. With the orebody remaining open at depth and encouraging early drilling outside current reserves, investors can expect continued efforts to grow resources and sustain the mine’s future.

    The company is also progressing environmental permit approvals to cover operations beyond 2035, aiming for a seamless transition to an extended mine life. Management highlights Sierra Gorda’s role as a cornerstone copper asset as global demand for key energy transition minerals rises.

    South32 share price snapshot

    The South32 share price has smashed the S&P/ASX 200 index (ASX: S32) over the past 12 months with a gain of over 70%.

    View Original Announcement

    The post South32 share price in focus as Sierra Gorda mine life jumps with 61% reserve boost appeared first on The Motley Fool Australia.

    Should you invest $1,000 in South32 right now?

    Before you buy South32 shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and South32 wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

  • Aurelia Metals appoints Steve Badenhorst as new CEO to lead next growth phase

    CEO of a company talking.

    The Aurelia Metals Ltd (ASX: AMI) share price is in focus today after the company announced the appointment of Mr Steve Badenhorst as its new Managing Director and Chief Executive Officer, set to begin on 6 October 2026.

    What did Aurelia Metals report?

    • Appointment of Steve Badenhorst as Managing Director and Chief Executive Officer
    • Badenhorst brings 35+ years of global mining and operational leadership experience
    • Recent leadership roles include Group Head of Asset Management at Rio Tinto and COO at Rio Tinto Aluminium Pacific Operations
    • TFR (Total Fixed Remuneration) of $732,500 per annum, plus short- and long-term incentives
    • Badenhorst commences on 6 October 2026

    What else do investors need to know?

    Aurelia Metals operates three underground base metal mines across its Peak and Federation sites in the Cobar Basin, NSW, and is developing its Great Cobar copper project. The appointment follows a comprehensive recruitment process to secure a leader with strong operational credentials and long-term strategic vision.

    Outgoing interim CEO Martin Cummings will step down when Badenhorst begins his role. Aurelia’s board expressed gratitude for Cummings’ leadership during the transition period.

    What did Aurelia Metals management say?

    Commenting on his appointment, Steve Badenhorst said:

    I am honoured to be appointed Managing Director and Chief Executive Officer of Aurelia, to lead the Company through its next phase of growth. Aurelia has a high quality asset base, a strong team and significant opportunities to create value through safe, predictable operational performance, resource development and continued exploration success.

    I am excited to return to underground hard rock mining and look forward to working closely with the Board and the Executive Leadership Team to execute the Company’s strategy to realise the potential of the Company’s operations and highly prospective exploration portfolio to create long-term value for shareholders.

    What’s next for Aurelia Metals?

    With Mr Badenhorst set to start in early October, Aurelia Metals will soon be under experienced new leadership expected to drive its growth strategy forward. The company aims to deliver on its plans for resource development and to progress major projects like Great Cobar, focusing on creating sustainable long-term value for shareholders.

    Investors can watch for updates on strategic initiatives, operational improvements, and exploration results as the new CEO settles in.

    Aurelia Metals share price snapshot

    Over the past 12 months, Aurelia Metals shares have risen 116%, significantly outperforming the All Ordinaries Index (ASX: XAO).

    View Original Announcement

    The post Aurelia Metals appoints Steve Badenhorst as new CEO to lead next growth phase appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Aurelia Metals right now?

    Before you buy Aurelia Metals shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Aurelia Metals wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

  • Neuren share price in focus after DAYBU wins EU approval for Rett syndrome

    Two lab workers fist pump each other.

    The Neuren Pharmaceuticals Ltd (ASX: NEU) share price is in focus after its global partner, Acadia Pharmaceuticals, secured European approval for DAYBU (trofinetide) – the first treatment for Rett syndrome in the EU. Neuren stands to receive US$35 million upon the drug’s first commercial sale in Europe, plus potential milestone payments.

    What did Neuren report?

    • The European Commission has granted marketing authorisation for DAYBU (trofinetide) for Rett syndrome.
    • DAYBU is the first and only approved treatment for Rett syndrome in the European Union.
    • Neuren to receive US$35 million from the first European commercial sale, with milestone payments up to US$170 million.
    • Tiered royalties from mid-teens to low 20s percent of net sales are also expected under the partnership.
    • Commercial launch in Germany is targeted for early Q4 2026.

    What else do investors need to know?

    The European approval means DAYBU can be marketed across all 27 EU member states, as well as Iceland, Liechtenstein, and Norway. This milestone further extends the reach of trofinetide, which is already approved in the United States, Canada, and Israel.

    Neuren’s other clinical program, NNZ-2591, is progressing with a Phase 3 clinical trial for Phelan-McDermid syndrome and open-label extension studies. Each of Neuren’s drug development programs has been granted “orphan drug” status in both the US and EU.

    What did Neuren management say?

    Neuren CEO Jon Pilcher said:

    We are delighted for the Rett syndrome community in Europe, who, until now, have had no approved treatment for this devastating condition. The European Commission’s approval of DAYBU is particularly rewarding for Neuren given our long-standing commitment to developing therapies for serious neurological disorders with profound unmet need. We look forward to seeing our partner Acadia make DAYBU available for Rett patients and families in Europe.

    What’s next for Neuren?

    With European marketing authorisation, Acadia plans to launch DAYBU in Germany in early Q4 2026, which will trigger Neuren’s first commercial milestone payment. Ongoing development of NNZ-2591, now in late-stage trials for several neurodevelopmental disorders, remains a key priority for future growth.

    Neuren continues to target serious neurological conditions where few approved treatments exist, aiming to advance both its existing partnerships and its internal drug pipeline.

    Neuren share price snapshot

    The Neuren Pharmaceuticals share price has outperformed the S&P/ASX 200 index (ASX: XJO) over the past 12 months with a gain of approximately 27%.

    View Original Announcement

    The post Neuren share price in focus after DAYBU wins EU approval for Rett syndrome appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Neuren Pharmaceuticals right now?

    Before you buy Neuren Pharmaceuticals shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Neuren Pharmaceuticals wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

  • Why I’d buy this top ASX dividend share for major passive income today

    Passive income word cloud on a digital tablet, with a cup of coffee and biscuit at the side.

    The ASX dividend share MFF Capital Investments Ltd (ASX: MFF) is one of the leading choices for passive income, in my view.

    It may not be as popular as names like BHP Group Ltd (ASX: BHP), Commonwealth Bank of Australia (ASX: CBA) or Woolworths Group Ltd (ASX: WOW). But, I think MFF is better than each of those ASX blue-chip shares for multiple reasons.

    Let’s get into what makes it such a good buy.

    Diversification

    Each of the large ASX companies I mentioned above is an impressive business with significant operations.

    However, an investment with MFF offers much more diversification because it owns a portfolio of shares, whereas the ASX blue-chips are singular businesses.

    MFF aims to invest in competitively advantaged businesses, which are normally global blue-chip stocks.

    Its largest holdings are names like Mastercard, Alphabet, Visa, Bank of America and Amazon.

    The ASX dividend share’s holdings have been long-term winners, and I believe there’s a good chance they will continue to be long-term compounders.

    Past performance is not a guarantee of future performance, but MFF’s portfolio has delivered strong returns over the long-term.

    According to CMC Invest, over the past five years MFF has delivered an average total shareholder return (TSR) of 16.2% per year.

    I think its investment strategy can continue to perform well over the long-term and I expect its portfolio will continue to adjust over the years.

    Dividend yield

    One of the best reasons to like this ASX dividend share is down to its impressive dividend yield, which is superior to the ASX blue chip shares of CBA, BHP and Woolworths.

    The business has provided guidance that it intends its next half-year dividend will be 12 cents per share and I expect the one after that will be 13 cents per share.

    Assuming the business does pay an annual dividend per share of 25 cents per share in the 2027 financial year, it would represent a grossed-up dividend yield of 6.8%, including franking credits, at the time of writing.

    Payout growth

    Dividend growth is not a guarantee of course, but the business has a goal of increasing its dividend for investors each year and its large profit reserve and profit generation mean the business is able to pay consistently growing dividends.

    In FY26 it grew its annual dividend per share by 23.5%, and I expect it will grow the dividend by another 19%. In my view, there are not many ASX dividend shares with yields above 6% that are likely to grow their payout at that pace.

    MFF has grown its annual dividend per share each year since FY18, so it’s building a pleasing track record of regular payout growth.

    This ASX dividend share is one of the largest positions in my portfolio, and I’m expecting more pleasing payouts in the years to come.

    The post Why I’d buy this top ASX dividend share for major passive income today appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Mff Capital Investments right now?

    Before you buy Mff Capital Investments shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Mff Capital Investments wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Bank of America is an advertising partner of Motley Fool Money. Motley Fool contributor Tristan Harrison has positions in Mff Capital Investments. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Alphabet, Amazon, Mastercard, and Visa. The Motley Fool Australia has positions in and has recommended Mff Capital Investments. The Motley Fool Australia has recommended Alphabet, Amazon, Mastercard, and Visa. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Nanosonics posts FY26 revenue growth and prepares to launch CORIS

    Teamwork, planning and meeting with doctors and laptop for medical, review and healthcare. Medicine, technology and internet with group of people for collaboration, diversity and support in hospital

    The Nanosonics Ltd (ASX: NAN) share price is in focus today after the company posted FY26 revenue of $203.9 million, up 3% on the prior year, and reported strong growth in trophon unit placements and successful launches of next-generation devices.

    What did Nanosonics report?

    • Revenue increased 3% on prior corresponding period (pcp) to $203.9 million, or 6% on a constant currency basis to $211.5 million
    • EBIT came in at $16.0 million, down 10% on pcp, but up 21% to $21.6 million at constant currency
    • trophon-only EBIT was $50.6 million, a 5% increase on pcp (16% at constant currency)
    • Total trophon unit placements rose 9% to 4,230 units, with global installed base up 6% to 39,230 devices
    • Cash and cash equivalents stood at $155.2 million as at 30 June 2026, and the company remains debt free
    • $20 million share buyback completed, with a new buyback of up to $40 million announced for FY27

    What else do investors need to know?

    Nanosonics launched its next generation trophon3 and trophon2 Plus systems during FY26, seeing accelerating adoption in the second half of the year. North America was a key driver, with record device upgrades up 32% on last year.

    The company continued making headway with the CORIS System, progressing through a Controlled Market Release and receiving favourable customer feedback. Regulatory milestones were achieved, including approvals in major markets and FDA clearances.

    What did Nanosonics management say?

    CEO and President said Michael Kavanagh said:

    Nanosonics is entering a defining period of growth. FY26 demonstrated the strength of the business we have built: a proven trophon franchise, disciplined financial execution and in FY27 we will progress the CORIS System from CMR to commercialisation.

    What’s next for Nanosonics?

    Looking ahead, Nanosonics expects continued revenue growth driven by its expanding trophon installed base, upgrades, and consumables and services. The commercial launch of CORIS is planned across the UK, Ireland and Australia in the first half of FY27, with the US to follow.

    The company has flagged a deliberate increase in operational expenses to support the CORIS commercialisation, but remains well-funded to pursue long-term opportunities. FY27 revenue guidance is between $220 million and $228 million (constant currency) with gross margin expected to moderate as new investments ramp up.

    Nanosonics share price snapshot

    Over the past 12 months, Nanosonics shares have declined 10%, trailing the All Ordinaries Index (ASX: XAO), which has risen 1% over the same period.

    View Original Announcement

    The post Nanosonics posts FY26 revenue growth and prepares to launch CORIS appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Nanosonics right now?

    Before you buy Nanosonics shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Nanosonics wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Nanosonics. The Motley Fool Australia has recommended Nanosonics. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

  • Electro Optic Systems half-year earnings surge on booming defence demand

    Two work colleagues looking at a laptop and discussing something.

    The Electro Optic Systems Holdings Ltd (ASX: EOS) share price is on watch today after the company unveiled surging half-year revenue, which jumped 283% to $168.8 million, though its net loss after tax narrowed to $32.9 million.

    What did Electro Optic Systems report?

    • Revenue from continuing operations up 283% to $168.8 million (1H FY25: $44.1 million)
    • Net loss after tax attributable to members reduced to $32.9 million (1H FY25: loss of $44.8 million)
    • Underlying EBITDA from continuing operations swung to a profit of $21.6 million (1H FY25: $14.9 million loss)
    • No interim dividend declared
    • Contracted order book grew to approximately $846 million (1H FY25: $170 million)
    • Net assets stood at $391.6 million at 30 June 2026, with cash and equivalents at $256 million

    What else do investors need to know?

    Electro Optic Systems completed its acquisition of the MARSS Group in May, boosting its offering in the fast-growing counter-drone and advanced defence tech sector. The MARSS business is now integrated with EOS’s Defence Systems division, strengthening the group’s position in Europe and the Middle East.

    The half also saw EOS undertake a major $190 million capital raise and secure a new $100 million loan facility, of which $70 million has been drawn. The company continues to invest heavily in research and development, with a particular focus on high-energy laser weapons and fully integrated counter-drone solutions.

    What’s next for Electro Optic Systems?

    EOS expects continued strong demand driven by defence spending and escalating interest in counter-drone technologies globally. The company’s contracted order book now stands at $846 million, underpinning future revenue.

    Management forecasts full-year 2026 revenue (including MARSS) of $360 million to $400 million—potentially a record result—assuming global supply chains remain steady. The company says it will keep the market updated as major deals progress, especially in key regions like Europe, the Middle East, and North America.

    Electro Optic Systems share price snapshot

    The EOS share price has been among the best performers on the S&P/ASX 200 index (ASX: XJO) over the past 12 months with a gain of 70%.

    View Original Announcement

    The post Electro Optic Systems half-year earnings surge on booming defence demand appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Electro Optic Systems right now?

    Before you buy Electro Optic Systems shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Electro Optic Systems wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Electro Optic Systems. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.